Results 221 to 230 of about 389,222 (268)
Some of the next articles are maybe not open access.
The Lancet, 2021
Arterial hypertension is the most important contributor to the global burden of disease; however, disease control remains poor. Although the diagnosis of hypertension is still based on office blood pressure, confirmation with out-of-office blood pressure measurements (ie, ambulatory or home monitoring) is strongly recommended.
Brouwers, Sofie +3 more
openaire +3 more sources
Arterial hypertension is the most important contributor to the global burden of disease; however, disease control remains poor. Although the diagnosis of hypertension is still based on office blood pressure, confirmation with out-of-office blood pressure measurements (ie, ambulatory or home monitoring) is strongly recommended.
Brouwers, Sofie +3 more
openaire +3 more sources
Pulmonary arterial hypertension
Medicina Clínica (English Edition), 2022Pulmonary arterial hypertension (PAH) is a rare disease characterized by adverse remodeling of the arterial tree leading to increased vascular resistance with subsequent increase in right ventricular afterload and eventual development of heart failure.
Raquel, Luna-López +2 more
openaire +2 more sources
Pulmonary arterial hypertension
La Presse Médicale, 2023Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by remodelling of the pulmonary arteries and progressive narrowing of the pulmonary vasculature. This leads to a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure and, if left untreated, to right ventricular failure and death.
Athénaïs Boucly +7 more
openaire +2 more sources
Risks for Arterial Hypertension
Cardiology Clinics, 1986In this article, the most important risk factors that may predict the transition from borderline to established hypertension are reviewed. Primary prevention has to focus on identifying individuals who are at highest risk and delaying or reversing further elevation of arterial pressure levels.
R E, Schmieder, F H, Messerli, H, Ruddel
openaire +2 more sources
Pulmonary Arterial Hypertension
Heart Failure Clinics, 2018This article provides an overview of pulmonary arterial hypertension (PAH), beginning with the initial pathologic recognition of pulmonary hypertension more than 100 years ago and progressing to the current diagnostic categorization of PAH. It reviews the epidemiology, pathophysiology, genetics, and modern treatment of PAH.
Mark W, Dodson +2 more
openaire +2 more sources
Aldosterone and arterial hypertension
Nature Reviews Endocrinology, 2009In the setting of primary aldosteronism, elevated aldosterone levels are associated with increased blood pressure. Aldosterone concentrations within the normal range, however, can also alter blood pressure. Furthermore, the aldosterone-to-renin ratio, an indicator of aldosterone excess, is associated with hypertension, even in patients without ...
Andreas, Tomaschitz +4 more
openaire +2 more sources
The Kidney and Arterial Hypertension
Drugs, 1993It has been known for some time that a relationship exists between the kidney and blood pressure. The renal origin of arterial hypertension has been demonstrated in different animal models resembling human hypertension, with data from humans seeming to confirm this hypothesis.
L M, Ruilope, C, Campo, V, Lahera
openaire +2 more sources
Headache and arterial hypertension
Neurological Sciences, 2017Elevated blood pressure (BP) and headache have long been linked in the medical literature. Headache associated with arterial hypertension is a main concern in emergency department. It is believed that headache may be a symptom attributed to arterial hypertension only if the BP values are very high or rise quickly.
Cinzia, Finocchi, Davide, Sassos
openaire +2 more sources
Arterial hypertension and prediabetes
Medicina Clínica (English Edition), 2016The aim of this study was to assess the factors related to new diabetes in hypertensive.This prospective follow-up study involved 2588 non-diabetic, hypertensive patients. The total follow-up was 15053 patient-years with a median of 3.4 years (interquartile interval 1.4-6.8).During the follow-up 333 (13%) patients had new diabetes, with a conversion ...
Patricia, Boned Ombuena +3 more
openaire +2 more sources
Pulmonary Arterial Hypertension
Critical Care Nursing Quarterly, 2007Pulmonary arterial hypertension (PAH) is a rare and debilitating disease characterized by abnormal proliferation and contraction of pulmonary vascular smooth muscle cells. The resulting increase in pressure and pulmonary vascular resistance results in progressive right heart failure, low cardiac output, and ultimately death if left untreated.
openaire +2 more sources